Bronchiolitis Obliterans Syndrome Market 规模与份额分析 - 成长趋势与预测 (2024 - 2031)
Bronchiolitis Obliterans Syndrome Market is segmented By Therapy (Budesonide/Formoterol, Montelukast, N-acetylcysteine), By Drug Class (Macrolide Antibiotics, Corticosteroids, Immunosuppressive Drugs), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD Million) for the above-mentioned segments.
Bronchiolitis Obliterans Syndrome Market Size
市场规模（美元） Mn
复合年增长率4.1%
| 研究期 | 2024 - 2031 |
| 基准年 | 2023 |
| 复合年增长率 | 4.1% |
| 市场集中度 | Medium |
| 主要玩家 | Zambon Pharma, Incyte Corporation, Genentech, GlaxoSmithKline, Altavant Sciences and Among Others. |
please let us know !
Bronchiolitis Obliterans Syndrome Market Analysis
The bronchiolitis obliterans syndrome market is estimated to be valued at USD 60.37 Mn in 2024 and is expected to reach USD 79.93 Mn by 2031, growing at a compound annual growth rate (CAGR) of 4.1% from 2024 to 2031. The prevalence of bronchiolitis obliterans syndrome (BOS) is increasing which is driving the demand for effective therapeutics. With no approved drug therapy currently available for BOS, the pipeline drugs in late-stage clinical trials holds significant potential to capture market share if approved.